Table of Contents

1. Executive Summary

2. China In Vitro Diagnostics Market & Forecast (2010 – 2021)

3. China In Vitro Diagnostics Market Share & Forecast (2010 – 2021)
3.1 China In Vitro Diagnostics Market Share Outlook
3.2 China In Vitro Diagnostics Companies Share Outlook

4. China In Vitro Diagnostics Market – Segment Analysis (2010 – 2021)
4.1 China Clinical Chemistry Market & Forecast
4.2 China Immunoassay Market & Forecast
4.3 China Molecular Testing Market & Forecast
4.4 China Self–Monitoring of Blood Glucose (SMBG) Market & Forecast
4.5 China Point of Care Testing (POCT) Market & Forecast
4.6 China Hematology Market & Forecast
4.7 China Coagulation Market & Forecast
4.8 China Microbiology Market & Forecast

5. China In Vitro Diagnostics Market – Company Wise Sales Analysis (2010 – 2021)
5.1 Roche Diagnostics – China IVD Sales & Forecast
5.2 Abbott Laboratories – China IVD Sales & Forecast
5.3 Mindray Medical International Limited – China IVD Sales & Forecast
5.4 Sysmex Corporation – China IVD Sales & Forecast
5.5 Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales & Forecast
5.6 Other Companies – China IVD Sales & Forecast

6. China IVD – Regulation & its Latest Development

7. China IVD – Future Prospects in Attractive In Vitro Diagnostics Segments

8. China IVD – Regional Trends & Opportunities

9. China IVD – Main Participants/Contributors
9.1 China IVD Market – Main Distributors
9.2 China IVD Market – Major Laboratories
9.3 China IVD Market – Major Foreign & Regional Companies

10. China – Major IVD Product Companies Outlook
10.1 Mindray Medical International Limited
10.2 Shanghai Fosun Pharmaceutical Group
10.3 Mingyuan Medicare
10.4 Da An Gene Co. Ltd
10.5 Shanghai Kehua Bio–Engineering Co. Ltd

11. China – Major Private Clinical Labs & Diagnostic Services Companies Outlook
11.1 Zhejiang D.a. Diagnostics Technology Co., Ltd
11.2 ADICON Clinical Laboratories (Privately held)
11.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
11.4 Kindstar Global
11.5 BGI – Shenzhen
11.6 OriGene Technologies

12. China In Vitro Diagnostics Market – Growth Drivers
12.1 China Healthcare Reforms – A Progress to Date & Next Steps
12.2 Upgradation of Automated Testing Levels & Investment by Government in Hospitals Will Drive the China IVD Industry
12.3 Public Health Awareness & Increased Incidence of Hypertension, Cardio Cerebrovascular Illness, Diabetes, Arthritis & Cancer
12.4 Increasing Number of Private Hospitals & Independent Testing Laboratories Boost the Demand of IVD Testing in China

13. China In Vitro Diagnostics Market – Challenges
13.1 Value Added Markets of New Products & Household Consumption Markets
13.2 Low Reimbursement Rate of the Basic Medical Care Insurance for Clinical Tests Will Discourage the People from IVD Tests.
13.3 Absence of Quality Products By the Local Companies Hindrance the Growth of IVD Market in China
13.4 Population Factors
13.5 Foreign Companies Faces Difficulty to Enter the Low End IVD Products Market in China
13.6 Reimbursement Rates Differ in Many Parts of China Which Creates Problems To Popularizing the IVD Products

List of Tables:

Table 3–1: China – In Vitro Diagnostics Market Share(Percent),2010 – 2015
Table 3–2: China – In Vitro Diagnostics Market Share(Percent),2016 – 2021

List of Figures:

Figure 2–1: China – IVD Market (Million US$), 2010 – 2015
Figure 2–2: China – Forecast for IVD Market (Million US$), 2016 – 2021

Figure 3–1: China – In Vitro Diagnostics Companies Share(Percent), 2015

Figure 4–1: China – Clinical Chemistry Market (Million US$), 2010 – 2015
Figure 4–2: China – Forecast for Clinical Chemistry Market (Million US$), 2016 – 2021
Figure 4–3: China – Immunoassay Market (Million US$), 2010 – 2015
Figure 4–4: China – Forecast for Immunoassay Market (Million US$), 2016 – 2021
Figure 4–5: China – Molecular Testing Market (Million US$), 2010 – 2015
Figure 4–6: China – Forecast for Molecular Testing Market (Million US$), 2016 – 2021
Figure 4–7: China – SMBG Market (Million US$), 2010 – 2015
Figure 4–8: China – Forecast for SMBG Market (Million US$), 2016 – 2021
Figure 4–9: China – POCT Market (Million US$), 2010 – 2015
Figure 4–10: China – Forecast for POCT Market (Million US$), 2016 – 2021
Figure 4–11: China – Hematology Market (Million US$), 2010 – 2015
Figure 4–12: China – Forecast for Hematology Market (Million US$), 2016 – 2021
Figure 4–13: China – Coagulation Market (Million US$), 2010 – 2015
Figure 4–14: China – Forecast for Coagulation Market (Million US$), 2016 – 2021
Figure 4–15: China – Microbiology Market (Million US$), 2010 – 2015
Figure 4–16: China – Forecast for Microbiology Market (Million US$), 2016 – 2021

Figure 5–1: Roche Diagnostics – China IVD Sales (Million US$), 2010 – 2015
Figure 5–2: Roche Diagnostics – Forecast for China IVD Sales (Million US$), 2016 – 2021
Figure 5–3: Abbott Laboratories – China IVD Sales (Million US$),2012 – 2015
Figure 5–4: Abbott Laboratories – Forecast for China IVD Sales (Million US$),2016 – 2021
Figure 5–5: Mindray Medical International Limited – China IVD Sales (Million US$),2010 – 2015
Figure 5–6: Mindray Medical International Limited – Forecast for China IVD Sales (Million US$),2016 – 2021
Figure 5–7: Sysmex Corporation – China IVD Sales (Million US$),2010 – 2015
Figure 5–8: Sysmex Corporation – Forecast for China IVD Sales (Million US$),2016 – 2021
Figure 5–9: Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales (Million US$),2011 – 2015
Figure 5–10: Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales (Million US$),2016 – 2021

Figure 9–1: Kindstar – Collaboration with hospitals in China (Number), 2006 – 2012